4//SEC Filing
Lochner Daniel 4
Accession 0001209191-22-002978
CIK 0001720725other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 7:45 PM ET
Size
7.9 KB
Accession
0001209191-22-002978
Insider Transaction Report
Form 4
Lochner Daniel
Chief Financial Officer
Transactions
- Award
Common Stock
2022-01-09+19,500→ 77,721 total - Award
Employee Stock Option (Right to Buy)
2022-01-09−87,900→ 87,900 totalExercise: $16.00Exp: 2032-01-08→ Common Stock (87,900 underlying)
Footnotes (3)
- [F1]Represents a grant of restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
- [F2]25% of the RSUs vest on January 7, 2023 and the remainder vest annually thereafter, in equal amounts, on the same day of the month as the grant date over the following 3 years, subject to the Reporting Person's continuous service to the Issuer through each such date.
- [F3]Options granted on January 9, 2022 under the Oyster Point Pharma, Inc. 2019 Equity Incentive Plan. 25% of the options shall vest and become exercisable on January 7, 2023 and one thirty-sixth (1/36) of the remaining options shall vest monthly thereafter on the same day of the month (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service to the Issuer through each such date.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001791187
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 7:45 PM ET
- Size
- 7.9 KB